Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5501-5507, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The EspB Protein of Enteropathogenic
Escherichia coli Is Targeted to the Cytoplasm of Infected
HeLa Cells
Kathleen A.
Taylor,1
Colin B.
O'Connell,1,2
Paul W.
Luther,3 and
Michael S.
Donnenberg1,2,*
Division of Infectious Diseases, Department
of Medicine,1
Department of Molecular
Microbiology and Immunology,2 and
Department of Physiology,3 University of
Maryland School of Medicine, Baltimore, Maryland 21201
Received 17 February 1998/Returned for modification 18 March
1998/Accepted 21 August 1998
 |
ABSTRACT |
The EspB protein of enteropathogenic Escherichia coli
(EPEC) is exported via a type III secretion apparatus. EspB is critical for signaling the host cell and for the development of the attaching and effacing lesion characteristic of EPEC infection. We used cellular fractionation and confocal laser scanning microscopy to
determine the cellular location of EspB during infection of HeLa cells.
Both methods indicated that EspB is targeted to the cytoplasm of
infected cells. Using mutants, we found that EspB targeting to the host
cell cytoplasm requires the type III secretion apparatus and
the secreted proteins EspA and EspD, but not intimin. These results
provide insights into the function of the type III secretion apparatus
of EPEC and the functions of the Esp proteins.
 |
INTRODUCTION |
Enteropathogenic Escherichia
coli (EPEC) is a leading cause of infantile diarrhea in developing
countries throughout the world. EPEC forms clusters of bacteria on the
surface of infected epithelial cells in a pattern referred to as
localized adherence. Subsequently, signals are transduced to the
host cell via the secretion of several EPEC effector molecules.
This signaling cascade culminates in the formation of the
attaching and effacing lesion, which is characterized by intimate
attachment of the bacteria and localized degeneration of the
epithelial microvilli (reviewed in reference
9). Highly organized cytoskeletal structures,
referred to as pedestals, form directly beneath adherent
bacteria. These pedestals are composed of actin filaments and several
other cytoskeletal proteins (12, 23).
The bacterial genes that encode all of the factors necessary for
pedestal formation are found within a large pathogenicity island in the
E. coli chromosome known as the LEE (28) (for locus of enterocyte effacement), which is roughly organized into three
regions (11). Many of the genes located in the left-hand region of the island encode a type III secretion apparatus, which exports several effector molecules encoded by genes located in the
right-hand region (16). Between these regions are the gene eae, which encodes the bacterial adhesin intimin
(17), and a recently identified gene that encodes Tir. Upon
translocation into the host cell membrane, Tir becomes tyrosine
phosphorylated and serves as the receptor for intimin (19).
Intimin is a 94-kDa outer membrane protein that is required for
intimate adherence of EPEC to the epithelial cell membrane (8,
18). Mutants defective in eae are unable to sharply
focus cytoskeletal components under adherent bacteria (6),
although the signal transduction process remains intact
(33). At least three proteins secreted by EPEC, EspB, EspA,
and EspD, are involved in activating signals in infected epithelial
cells (13, 22, 26). These signals include calcium and
inositol phosphate fluxes (1, 10, 14); activation of
phospholipase C-
(21), protein kinase C (5),
and NF-
B (35); and changes in membrane potential and
short-circuit current (4, 38). The Esp proteins are also required for tyrosine phosphorylation of the Tir protein (13, 22,
26). Signaling through these proteins must occur prior to
intimate attachment of the bacteria. Mutations in espB,
espA, or espD or those in the type III secretion
apparatus (esc, formerly cfm, and sep)
render EPEC unable to signal or to induce the formation of
attaching and effacing lesions. Genetic analysis has also shown that
the translocation of Tir into the host cell membrane requires EspB,
EspA, and the type III secretion apparatus (19). In contrast to EspA, EspB adopts a protease-resistant form upon contact between EPEC and epithelial cells (20). This finding suggests that
EspA and EspB have separate functions in the signal transduction
process. In this study, we present the results of experiments designed to determine whether EspB is delivered to the host
cytoplasm during infection.
 |
MATERIALS AND METHODS |
Bacterial strains and tissue culture.
EPEC E2348/69 and
isogenic mutants CVD206 (eae), UMD864
(espB), UMD872 (espA), UMD870 (espD),
and CVD452 (escN) have been described previously
(8, 13, 16, 22, 26). These bacteria were routinely cultured
in Luria-Bertani (LB) broth or on LB plates. To induce EPEC virulence
factor expression, the bacteria were grown in DMEM/F12 (Gibco-BRL,
Gaithersburg, Md.). Plasmid pIL14 (25) was introduced into
electrocompetent cells of CVD452, UMD864, UMD870, and UMD872 as
previously described (26). HeLa cells (ATCC CCL2) were
seeded (106 per well) in six-well tissue culture plates in
Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol)
fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 µg/ml) and incubated overnight in an atmosphere of 95% air-5%
CO2 at 37°C.
Cellular fractionation.
One-half hour prior to infection,
HeLa cells were washed with phosphate-buffered saline (PBS) and
incubated with DMEM/F12 lacking additives. Bacteria grown overnight in
LB broth were diluted 1:100 into DMEM/F12 and grown at 37°C in an
atmosphere of 95% air-5% CO2 for 4 h. HeLa cell
monolayers were infected with 3-ml volumes of each EPEC culture for
1 h. Four fractions were obtained from these infections as
follows. First, the culture supernatant was removed, combined with PBS
washes of the HeLa cell monolayer, and subjected to centrifugation
(14,000 × g; 10 min; room temperature) to yield a
pellet (fraction 1) that contained nonadherent bacteria. The
supernatant was then passed through a 0.2-µm filter to remove any
residual bacteria, yielding a filtrate (fraction 2) that contained secreted proteins not associated with the host cell. This fraction was
concentrated by precipitation with trichloroacetic acid and resuspended
in sample buffer containing 10% (vol/vol) saturated Tris base.
Infected HeLa cell monolayers were lysed in a buffer consisting of 0.25 M Tris-HCl, pH 7.5, phenylmethylsulfonyl fluoride (50 µg/ml),
aprotinin (0.5 µg/ml), and EDTA (0.5 µM) by three freeze-thaw
cycles consisting of alternating 5-min incubations in a dry ice-ethanol
bath and a water bath set at 37°C. Lysates were subjected to
ultracentrifugation (100,000 × g; 1 h; 4°C). This procedure yielded two fractions: a supernatant fraction containing soluble cytoplasmic contents (fraction 3) and a pellet consisting of
adherent bacteria, HeLa cell membranes, nuclei, and cytoskeletal proteins (fraction 4). Equivalent volumes of these fractions were analyzed on sodium dodecyl sulfate (SDS)-12% polyacrylamide gels and
electrotransferred in Towbin's buffer (39) to
polyvinylidene difluoride membranes (Immobilon-P; Millipore,
Bedford, Mass.). In some experiments, HeLa cell cultures were treated
with either cytochalasin D (2 µM) or genistein (250 µM) prior to
and during the infection process.
Antibodies.
Primary antibodies were diluted in PBS-0.1%
Tween 20 for immunoblotting. A monoclonal antibody to phospholipase
C-
was provided by M. Chedid, National Institutes of Health,
and was used in the form of undiluted ascites fluid. A monoclonal
antibody to the human fibronectin receptor was provided by R. Isberg,
Tufts University, and was used at a dilution of 1:4,000. A polyclonal
antibody against the EPEC adhesin intimin has been previously described
(17) and was used at a dilution of 1:1,000. A previously
described polyclonal antiserum against EspB (31) was
affinity purified with the peptide to which the antiserum was raised
immobilized on a column (Aminolink; Pierce, Rockford, Ill.) according
to the manufacturer's instructions and was used at a dilution of
1:100. Membranes were blocked in PBS containing 0.5% (vol/vol) Tween 20 and 5% (wt/vol) nonfat dry milk and were developed with secondary antibodies conjugated to alkaline phosphatase and
5-bromo-4-chloro-3-indolylphosphate and nitroblue tetrazolium (Sigma,
St. Louis, Mo.) or with secondary antibody conjugated to horseradish
peroxidase and enhanced chemiluminescence reagents (Amersham,
Naperville, Ill.).
Confocal microscopy.
HeLa cells were incubated on coverslips
that were placed in 24-well plates in DMEM/F12 supplemented with 10%
fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 µg/ml) and incubated in an atmosphere of 95% air-5%
CO2 until 85% confluence was reached. Overnight static
cultures of EPEC strains grown in LB broth at 37°C were diluted 1:100
in DMEM/F12 without additives and incubated with aeration for 3 h
at 37°C. HeLa cell cultures were washed three times with PBS, and the
medium was replaced with DMEM/F12 without additives. One-milliliter
volumes of EPEC cultures were added to 1 ml of base medium overlaying
the HeLa cell monolayers and centrifuged at 800 × g
for 10 min. Infected HeLa monolayers were incubated in an atmosphere of
95% air-5% CO2 at 37°C for 3 h. Following
infection, the cell monolayers were washed extensively in PBS, fixed
with 2% formaldehyde, and permeabilized with 0.1% Triton X-100. The
fixed monolayers were initially stained with
4',6'-diamidino-2-phenylindole (DAPI; Sigma) (5 µg/ml in
H2O) for 1 h. This compound, which binds to DNA and fluoresces bright blue after excitation with a UV laser, was used to
label adherent bacteria and host cell nuclei. The monolayers were then
blocked overnight at 4°C in 3% bovine serum albumin (BSA)-0.2%
sodium azide. All subsequent antibody treatments were performed at room
temperature for 3 h. The affinity-purified anti-EspB antibody was
used at a dilution of 1:10 in 0.3% BSA in PBS and detected in stained
cells with an anti-rabbit immunoglobulin G antibody conjugated to
lissamine rhodamine B (Molecular Probes, Eugene, Oreg.) at a dilution
of 1:200 in 0.3% BSA-PBS. Filamentous actin was detected with
fluorescein isothiocyanate-phalloidin (5 µg/ml) in PBS. The samples
were examined with a Zeiss LSM410 confocal laser scanning microscope
with a 63×, numerical aperture 1.4 objective. Fluorescein and
lissamine rhodamine signals were excited with the 488- and 568-nm lines
of a 50-mW KrAr laser and detected through 515- to 540-nm band-pass and
590-nm long-pass filters, respectively. DAPI fluorescence was excited
with the 351- and 364-nm lines of a 100-mW Ar UV laser and detected
through a 472.5- to 492.5-nm band-pass filter. The diameter of the
detector pinhole corresponded to one Airy unit at 590 nm, which
corresponds to an optical thickness of 1 µm along the z
axis. Conditions for laser attenuation and detector black level and
gain were established by using cultures infected with wild-type EPEC,
and these settings were maintained for the other samples. Image
analysis was performed with LSM410 software.
 |
RESULTS |
Cellular fractionation of HeLa cells infected with EPEC.
To
determine whether EspB is targeted to the host cell cytoplasm, we
performed cellular fractionation experiments on HeLa cells that had
been infected with the prototypic wild-type EPEC strain, E2348/69, or
the isogenic espB mutant UMD864. Several primary antibodies
were employed to evaluate the purity of the fractions. We were
particularly concerned with the separation of the cytoplasmic and
membrane fractions of the infected HeLa cells, to allow us to
distinguish whether EspB gains access to the cytoplasm or interacts
with the host at the interface between the cell membrane and the
adherent bacteria. As seen in Fig. 1A, phospholipase C-
, a cytoplasmic enzyme, was detected only in the HeLa soluble lysate sample (fraction 3). In contrast, a diffuse signal representing glycosylated forms of the human fibronectin receptor, a membrane integrin, was detected only in the HeLa cell pellet sample (fraction 4). The bacterial outer membrane protein intimin was found in the pellet of the culture medium containing nonadherent bacteria (fraction 1) and in the pellet from the HeLa cell
lysate (fraction 4), which also contains adherent bacteria. These
results indicate that, within the detection limits of our assay, our
fractionation procedure successfully isolated HeLa cell membranes from
cytoplasm. These results also indicate that neither the bacterial
secreted protein fraction nor the soluble cytoplasmic fraction is
contaminated with whole bacteria.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Cellular fractionation of HeLa cells infected with
wild-type EPEC. Samples were derived from the pellet (lane 1) or
supernatant (lane 2) of the medium obtained from HeLa cells infected
with EPEC, from the lysate of the infected HeLa cells (lane 3), or from
the pellet of lysed infected cells (lane 4). Equivalent volumes of
these samples were separated by SDS-polyacrylamide gel electrophoresis,
transferred to membranes, and probed with a monoclonal antibody to
phospholipase C- (PLC- ), a monoclonal antibody to the human
fibronectin receptor, or a polyclonal antibody to the EPEC adhesin
intimin. (B) Detection of EspB in fractions from infected HeLa cells.
HeLa cell fractions, as defined for panel A, were separated by
SDS-polyacrylamide gel electrophoresis, transferred to membranes, and
probed with an affinity-purified anti-EspB antibody. Samples were
prepared from HeLa cells infected with wild-type EPEC E2348/69, with
the wild-type strain in the presence of cytochalasin D (cyto-D) or
genistein, and with espB mutant strain UMD864, as
indicated.
|
|
Similar fractions were analyzed with an affinity-purified antibody
against EspB. As expected, EspB was found in both the bacterial pellet
and the culture supernatant, corresponding to protein associated with
nonadherent bacteria and protein secreted into the medium (Fig. 1B).
EspB was also found in the HeLa cell lysate, but not in the pellet of
the high-speed centrifugation, indicating that the protein also
fractionates with the HeLa cell cytoplasm but not with the host cell
membrane. Furthermore, the absence of EspB in fraction 4, which
contains intimin, indicates that the bacteria adherent to the host cell
have undetectable levels of EspB. In contrast, both intimin and EspB
are detected in the fraction containing the nonadherent bacteria
(fraction 1). Neither cytochalasin D nor genistein inhibited the
association of EspB with the cytoplasmic fraction. Since these
compounds are potent inhibitors of EPEC invasion (7, 33),
these results indicate that fractionation of EspB with the host cell
cytoplasm does not require intracellular bacteria. When an
espB deletion mutant, UMD864, was tested in this assay, no
bands with the mobility of EspB were seen. Thus, cell fractionation
studies indicate that EspB is directed to the cytoplasm of host cells
during infection by EPEC.
Localization of EspB in infected HeLa cells by laser scanning
confocal microscopy.
We used confocal microscopy with the
affinity-purified EspB antibody to confirm the results obtained by cell
fractionation and to provide information on the subcellular location of
the protein. Figure 2 shows a stereo
image reconstructed from a series of optical sections taken at 0.5-µm
spacing from the surface through the basal border of a HeLa cell that
had been infected with wild-type EPEC bacteria. These images confirm
that the EspB signal can be found throughout the depth of an infected
cell, clearly indicating the intracellular location of the protein.
Figure 3 demonstrates the relationship
between EspB and other structures in HeLa cells infected with wild-type
EPEC bacteria. The EspB protein appears as an accumulation of bright
dots that coincide spatially with the plane in which condensed actin
appears directly under adherent bacteria. This result provides
additional evidence that EspB is targeted to the cytoplasm of infected
cells. Although at times colocalization of actin and EspB was observed,
as indicated by the fusion of the green and red signals to give a
yellow color, colocalization was not common. Instead, EspB was found
most often in the same vicinity as the actin, yet emitted a distinct
signal. We also observed that the EspB staining often radiated outward and downward from the perimeter of a defined bacterial colony, suggesting that the protein diffused somewhat from the point of entry
yet did not spread throughout the cytoplasm. An example of this effect
is seen in Fig. 3, where the bacterial colony associated with the EspB
in the cell on the left is out of the plane of the section. These
observations indicate that EspB is translocated into infected cells and
is localized in the vicinity of adherent bacteria.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
Stereo image of a HeLa cell infected with wild-type
EPEC. A series of 18 images, representing 0.5-µm optical sections in
the z axis, were taken of a representative HeLa cell stained
with an affinity-purified anti-EspB antiserum. The stereo image was
reconstructed from these sections.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Confocal laser scanning microscopy of HeLa cells
infected with wild-type EPEC. Bacterial and cellular nucleic acid was
labeled with DAPI (blue). Actin was labeled with fluorescein
isothiocyanate-phalloidin (green). EspB was labeled with
affinity-purified EspB antiserum and detected with a secondary antibody
against immunoglobulin G conjugated to lissamine rhodamine (red). Areas
of colocalization of EspB and actin appear yellow.
|
|
HeLa cells were also infected with the
escN (formerly
sepB) mutant, CVD452. Since this strain is defective in a
component
of the type III secretion apparatus, it is unable to secrete
any
of the Esp proteins or to induce epithelial signaling or actin
condensation (
16). As shown in Fig.
4B, the pattern of EspB
staining observed
was quite different from that seen in wild-type
infection. In this
case, the EspB antiserum stained the bacteria
on the HeLa cell surface.
In contrast to the wild type, punctate
cytoplasmic staining was not
observed in cells infected with the
escN mutant. The EspB
signal (red) colocalized with the DAPI signal
(blue), rendering most
bacteria purple. These results provide
further evidence that the
pattern of EspB staining seen in wild-type
infection represents
intracellular protein. This result also indicates,
as expected, that
the type III secretion apparatus is required
to deliver EspB to the
host cytoplasm.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 4.
Confocal laser scanning microscopy of HeLa cells
infected with wild-type and mutant EPEC. HeLa cell were infected with
wild-type bacteria (A), escN mutant CVD452 deficient in a
component of the type III secretion apparatus (B), eae
mutant CVD206 (C), espB mutant UMD864 (D), espA
mutant UMD872 (E), and espD mutant UMD870 (F). Labeling was
done as described in the legend to Fig. 3. Areas of colocalization of
EspB and actin appear yellow, and areas of colocalization of EspB and
nucleic acid appear purple.
|
|
Figure
4C shows HeLa cells infected with the
eae mutant,
CVD206 (
8). This mutant is defective in the gene encoding
intimin
and is unable to induce the highly organized cytoskeletal
pedestal
structures, leading to an immature attaching and effacing
lesion
referred to as an actin shadow when it is observed by
fluorescence
microscopy (
6). Despite this defect, this
mutant is able to
deliver Tir to host cells (
19,
33). As
shown here, the pattern
of EspB staining in CVD206 is similar to that
of wild-type EPEC.
These observations indicate that intimin is not
necessary for
targeting EspB to the cytoplasm of host cells.
We also infected HeLa cells with a series of mutants defective in each
of the
esp genes. Previous studies have determined
that
these mutants are unable to signal epithelial cells nor are
they able
to induce the reorganization of actin in infected cells
(
13,
22,
26). Fig.
4D, E, and F show infection with the
espB
mutant, the
espA mutant, and the
espD mutant,
respectively.
Each mutant in these experiments was negative for EspB
staining,
although colonies of bacteria could clearly be observed
adhering
to the epithelial cell surface. Although the
espA
and
espD mutants
secrete EspB, this result suggests that
EspB requires the other
Esp proteins for efficient translocation into
the host cytoplasm.
These results contrast with those obtained with the
escN mutant,
which stained purple due to colocalization of
EspB and the bacteria.
In the
esp mutants there was no
colocalization of EspB with the
bacteria. Therefore, in the
espA and
espD mutants, either all
of the EspB
made by these bacteria was secreted into the medium
or the protein was
not accessible to the antiserum as it was in
the
escN
mutant. These results also provide an explanation for
an earlier
observation. In previous experiments it was demonstrated
that
coinfection of host cells with an
eae mutant and either an
escV mutant (formerly
cfm or
sepA), an
espB mutant, or an
espA mutant results in
attaching and effacing lesions and invasion
levels similar to those
seen in wild-type infections (
13,
22,
33). The fact that the
eae mutant is able to deliver EspB to
the host cell
cytoplasm while
escN,
espA, and
espD
mutants are
not suggests that intracellular EspB is at least one factor
missing
from host cells infected with the signaling mutants, which is
supplied in
trans by the
eae mutant to allow
normal infection.
Similarly, since neither the
espA mutant
nor the
espB mutant is
able to deliver EspB to the host
cytoplasm, this also explains
the earlier observation that the
espA and
espB mutants are unable
to complement
each other in coinfection experiments (
22).
Since the
esp and
escN mutants bind to HeLa cells
at a lower density than does wild-type EPEC, these experiments do not
exclude
the possibility that our failure to observe EspB translocation
with these mutants was due to insufficient numbers of adherent
bacteria. To address this question, we introduced a plasmid that
encodes an afimbrial adhesin (AFA/I) of uropathogenic
E. coli into each of these mutants. Figure
5 shows HeLa cells infected
with the
espA mutant expressing AFA/I. Despite the greater density
of
bacteria binding to the cell monolayers in comparison to the
wild-type
strain, little or no intracellular EspB staining was
detected. Similar
results were obtained with the
espD and
espB mutants transformed with pIL14 and with the
escN mutant
transformed
with pIL14, except that in the last case many of the
bacteria
appeared purple due to colocalization of the DAPI and EspB
signals
(data not shown). This result demonstrates that the lack of
intracellular
EspB labeling in host cells infected with these mutants
is not
due to insufficient numbers of adherent bacteria. We conclude
that the EspA and EspD proteins and an intact type III secretion
apparatus are required for targeting EspB to the epithelial cell
cytoplasm.

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 5.
Confocal laser scanning microscopy of HeLa cells
infected with a hyperadherent mutant EPEC. HeLa cell samples were
infected with the espA mutant UMD872, which had been
transformed with a plasmid encoding an afimbrial adhesin. Labeling was
done as described in the legend to Fig. 3.
|
|
 |
DISCUSSION |
We have shown that EPEC targets the EspB protein to the host
cytoplasm of infected epithelial cells. Translocation of EspB requires
EspA and EspD as well as products of the type III secretion machinery.
This process does not, however, require the expression of the bacterial
adhesin intimin. Although EspA and EspD are required for the delivery
of EspB into the cytoplasm, we have little insight into how these
proteins function to achieve this purpose. A recent study suggests that
EspA is a component of a pilus on the surface of EPEC that may function
in adherence (24). Whether EspD is also a component of such
a structure is not known. One hypothesis is that these two proteins
form a translocation apparatus which functions to deliver EspB, as well
as the Tir protein, to the host cell. Similar functions have been
proposed for a pilus associated with the type III secretion system of
Pseudomonas syringae (32). Alternatively, it may
be necessary for EspB and EspD to form a complex that allows both
proteins to enter the cytoplasm. Formation of a translocation apparatus
may be the only function of EspA and EspD, or these proteins may share
a dual function as translocators and effectors by inducing signals at
the level of the host membrane or cytoplasm in the process
of translocating EspB. Similarly, while EspB enters the
cytoplasm, this protein is also required for the membrane
localization of Tir (19).
It is becoming increasingly clear that EPEC shares many features with
other pathogens, such as Yersinia, Salmonella,
Shigella, and Pseudomonas species, that use a
type III secretion apparatus to target effector molecules to host cells
(27, 29). Each of these pathogens uses this export system to
affect host cell signaling, yet each species appears to have different
and defined end points in this process. In recent studies it has been
shown that Salmonella typhimurium exports several type
III-dependent proteins known as Sips, which share many features with
EPEC Esp proteins. SipB and -C are both targeted to the host cell
cytoplasm, whereas SipA remains associated with the bacterial cell
surface (3). A fourth protein, SipD, is required for
translocation of the other Sips, but its function is not yet defined.
Two other proteins, SopE and SopB, have recently been reported to be
translocated into host cells by a Sip-dependent mechanism in
Salmonella dublin (15, 41). It is tempting to
draw analogies between the Sips and Sops of Salmonella and
the Esps of EPEC. Although sequence analysis shows no obvious amino
acid homologies, the functional similarities between these two groups
of effector molecules are compelling.
Yersinia species target several Yops to the host cytoplasm
(2, 30, 34, 36, 37). Undirected secretion of the Yop proteins occurs in low-calcium medium, but bacteria cultured in the
presence of epithelial cells target YopE and YopH to the host cell cytoplasm without secreting the proteins in the medium
(30, 34). In contrast, our findings with cell fractionation
suggest that in EPEC, secretion of EspB into the medium occurs in
addition to translocation into the host cell. However, cell
fractionation indicates that, in contrast to nonadherent bacteria,
bacteria adherent to the host cell contain undetectable levels of EspB, suggesting that secretion of EspB has been triggered by contact with
the host cell. Furthermore, no EspB colocalizing with adherent wild-type or esp mutant bacteria is detected by confocal
microscopy, whereas EspB colocalizes with adherent type III
secretion-deficient bacteria. These data indicate that secretion of
EspB is contact dependent. In previous studies we reported that,
although the espA and espD mutants secrete EspB,
they are incapable of signaling host cells (22, 26). In this
study we have determined that these mutants are not capable of
delivering EspB to the host cytoplasm, despite their ability to secrete
the protein.
The fact that most EspB does not directly colocalize with condensed
actin under adherent bacteria and the fact that this protein is not
capable of focusing actin in the absence of intimin suggest that the
direct function of EspB is not actin binding. It seems more likely that
this protein interacts with cellular signaling pathways that are
important in EPEC-induced cytoskeletal reorganization. It remains a
possibility that EspB functions merely to facilitate the entry of the
Tir protein, and apart from becoming the receptor for intimin, the Tir
protein itself may direct all of the signaling cascades observed. It is
equally possible that the Esps and Tir act in concert, with each
protein having distinct functions in cellular signaling.
EPEC is now firmly established as a member of a rapidly expanding group
of gram-negative bacteria that use a type III secretion apparatus to
insert bacterial effector molecules inside host cells. The interactions
between EspB, Tir, and the host cell may in fact be unique among this
group of pathogens. In any case, this system serves to emphasize the
complexity of pathogen-host interactions and will certainly provide
important insight for understanding similar interactions in other
pathogens.
 |
ACKNOWLEDGMENTS |
We thank Valentina Shustova for technical assistance and Marcio
Chedid and Ralph Isberg for supplying antibodies.
This work was supported by Public Health Service awards AI32074
(M.S.D.) and AI09651 (K.A.T.) from the National Institutes of Health
and IBN 9309510 from the National Science Foundation (P.W.L.). The
University of Maryland Facility for Confocal Microscopy was created
with National Science Foundation instrumentation grants BRI
9318061 and DBI 9512985.
 |
ADDENDUM |
Since submission of the manuscript, another group has reported
that EspB is targeted to the host cell cytoplasm (40). These authors also find that delivery of EspB to the cytoplasm requires both
EspA and EspB (24, 40).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Department of Medicine, University of Maryland
School of Medicine, 10 S. Pine St., MSTF-900, Baltimore, MD 21201. Phone: (410) 706-7560. Fax: (410) 706-8700. E-mail:
mdonnenb{at}umaryland.edu.
Editor:
P. E. Orndorff
 |
REFERENCES |
| 1.
|
Baldwin, T. J.,
W. Ward,
A. Aitken,
S. Knutton, and P. H. Williams.
1991.
Elevation of intracellular free calcium levels in HEp-2 cells infected with enteropathogenic Escherichia coli.
Infect. Immun.
59:1599-1604[Abstract/Free Full Text].
|
| 2.
|
Boland, A.,
M. P. Sory,
M. Iriarte,
C. Kerbourch,
P. Wattiau, and G. R. Cornelis.
1996.
Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y. enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.
EMBO J.
15:5191-5201[Medline].
|
| 3.
|
Collazo, C. M., and J. E. Galán.
1997.
The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell.
Mol. Microbiol.
24:747-756[Medline].
|
| 4.
|
Collington, G. K.,
I. W. Booth, and S. Knutton.
1998.
Rapid modulation of electrolyte transport in Caco-2 cell monolayers by enteropathogenic Escherichia coli (EPEC) infection.
Gut
42:200-207[Abstract/Free Full Text].
|
| 5.
|
Crane, J. K., and J. S. Oh.
1997.
Activation of host cell protein kinase C by enteropathogenic Escherichia coli.
Infect. Immun.
65:3277-3285[Abstract].
|
| 6.
|
Donnenberg, M. S.,
S. B. Calderwood,
A. Donohue-Rolfe,
G. T. Keusch, and J. B. Kaper.
1990.
Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells.
Infect. Immun.
58:1565-1571[Abstract/Free Full Text].
|
| 7.
|
Donnenberg, M. S.,
A. Donohue-Rolfe, and G. T. Keusch.
1990.
A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli.
FEMS Microbiol. Lett.
57:83-86[Medline].
|
| 8.
|
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317[Abstract/Free Full Text].
|
| 9.
|
Donnenberg, M. S.,
J. B. Kaper, and B. B. Finlay.
1997.
Interactions between enteropathogenic Escherichia coli and host epithelial cells.
Trends Microbiol.
5:109-114[Medline].
|
| 10.
|
Dytoc, M.,
L. Fedorko, and P. M. Sherman.
1994.
Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.
Gastroenterology
106:1150-1161[Medline].
|
| 11.
|
Elliott, S. J.,
L. A. Wainwright,
T. K. McDaniel,
K. G. Jarvis,
Y. Deng,
L.-C. Lai,
B. P. McNamara,
M. S. Donnenberg, and J. B. Kaper.
1998.
The complete sequence of the locus of enterocyte effacement (LEE) of enteropathogenic E. coli E2348/69.
Mol. Microbiol.
28:1-4[Medline].
|
| 12.
|
Finlay, B. B.,
I. Rosenshine,
M. S. Donnenberg, and J. B. Kaper.
1992.
Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.
Infect. Immun.
60:2541-2543[Abstract/Free Full Text].
|
| 13.
|
Foubister, V.,
I. Rosenshine,
M. S. Donnenberg, and B. B. Finlay.
1994.
The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells.
Infect. Immun.
62:3038-3040[Abstract/Free Full Text].
|
| 14.
|
Foubister, V.,
I. Rosenshine, and B. B. Finlay.
1994.
A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC), triggers a flux of inositol phosphates in infected epithelial cells.
J. Exp. Med.
179:993-998[Abstract/Free Full Text].
|
| 15.
|
Galyov, E. E.,
M. W. Wood,
R. Rosqvist,
P. B. Mullan,
P. R. Watson,
S. Hedges, and T. S. Wallis.
1997.
A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa.
Mol. Microbiol.
25:903-912[Medline].
|
| 16.
|
Jarvis, K. G.,
J. A. Girón,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000[Abstract/Free Full Text].
|
| 17.
|
Jerse, A. E., and J. B. Kaper.
1991.
The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.
Infect. Immun.
59:4302-4309[Abstract/Free Full Text].
|
| 18.
|
Jerse, A. E.,
J. Yu,
B. D. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843[Abstract/Free Full Text].
|
| 19.
|
Kenny, B.,
R. DeVinney,
M. Stein,
D. J. Reinscheid,
E. A. Frey, and B. B. Finlay.
1997.
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.
Cell
91:511-520[Medline].
|
| 20.
|
Kenny, B., and B. B. Finlay.
1995.
Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells.
Proc. Natl. Acad. Sci. USA
92:7991-7995[Abstract/Free Full Text].
|
| 21.
|
Kenny, B., and B. B. Finlay.
1997.
Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C- 1.
Infect. Immun.
65:2528-2536[Abstract].
|
| 22.
|
Kenny, B.,
L.-C. Lai,
B. B. Finlay, and M. S. Donnenberg.
1996.
EspA, a protein secreted by enteropathogenic Escherichia coli (EPEC), is required to induce signals in epithelial cells.
Mol. Microbiol.
20:313-323[Medline].
|
| 23.
|
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298[Abstract/Free Full Text].
|
| 24.
|
Knutton, S.,
I. Rosenshine,
M. J. Pallen,
I. Nisan,
B. C. Neves,
C. Bain,
C. Wolff,
G. Dougan, and G. Frankel.
1998.
A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells.
EMBO J.
17:2166-2176[Medline].
|
| 25.
|
Labigne-Roussel, A. F.,
D. Lark,
G. Schoolnik, and S. Falkow.
1984.
Cloning and expression of an afimbrial adhesin (AFA-I) responsible for P blood group-independent, mannose-resistant hemagglutination from a pyelonephritic Escherichia coli strain.
Infect. Immun.
46:251-259[Abstract/Free Full Text].
|
| 26.
|
Lai, L. C.,
L. A. Wainwright,
K. D. Stone, and M. S. Donnenberg.
1997.
A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells.
Infect. Immun.
65:2211-2217[Abstract].
|
| 27.
|
Lee, C. A.
1997.
Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells?
Trends Microbiol.
5:148-156[Medline].
|
| 28.
|
McDaniel, T. K.,
K. G. Jarvis,
M. S. Donnenberg, and J. B. Kaper.
1995.
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. USA
92:1664-1668[Abstract/Free Full Text].
|
| 29.
|
Mecsas, J. J., and E. J. Strauss.
1996.
Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.
Emerg. Infect. Dis.
2:270-288[Medline].
|
| 30.
|
Persson, C.,
R. Nordfelth,
A. Holmström,
S. Håkansson,
R. Rosqvist, and H. Wolf-Watz.
1995.
Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell.
Mol. Microbiol.
18:135-150[Medline].
|
| 31.
|
Rabinowitz, R. P.,
L.-C. Lai,
K. Jarvis,
T. K. McDaniel,
J. B. Kaper,
K. D. Stone, and M. S. Donnenberg.
1996.
Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction.
Microb. Pathog.
21:157-171[Medline].
|
| 32.
|
Roine, E.,
W. S. Wei,
J. Yuan,
E. L. Nurmiaho-Lassila,
N. Kalkkinen,
M. Romantschuk, and S. Y. He.
1997.
Hrp pilus: an hrp-dependent bacterial surface appendage produced by Pseudomonas syringae pv tomato DC3000.
Proc. Natl. Acad. Sci. USA
94:3459-3464[Abstract/Free Full Text].
|
| 33.
|
Rosenshine, I.,
M. S. Donnenberg,
J. B. Kaper, and B. B. Finlay.
1992.
Signal exchange between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induce tyrosine phosphorylation of host cell protein to initiate cytoskeletal rearrangement and bacterial uptake.
EMBO J.
11:3551-3560[Medline].
|
| 34.
|
Rosqvist, R.,
K.-E. Magnusson, and H. Wolf-Watz.
1994.
Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells.
EMBO J.
13:964-972[Medline].
|
| 35.
|
Savkovic, S. D.,
A. Koutsouris, and G. Hecht.
1997.
Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli.
Am. J. Physiol.
273:C1160-C1167.
|
| 36.
|
Sory, M.-P., and G. R. Cornelis.
1994.
Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells.
Mol. Microbiol.
14:583-594[Medline].
|
| 37.
|
Sory, M. P.,
A. Boland,
I. Lambermont, and G. R. Cornelis.
1995.
Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.
Proc. Natl. Acad. Sci. USA
92:11998-12002[Abstract/Free Full Text].
|
| 38.
|
Stein, M. A.,
D. A. Mathers,
H. Yan,
K. G. Baimbridge, and B. B. Finlay.
1996.
Enteropathogenic Escherichia coli (EPEC) markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells.
Infect. Immun.
64:4820-4825[Abstract].
|
| 39.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 40.
|
Wolff, C.,
I. Nisan,
E. Hanski,
G. Frankel, and I. Rosenshine.
1998.
Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli.
Mol. Microbiol.
28:143-155[Medline].
|
| 41.
|
Wood, M. W.,
R. Rosqvist,
P. B. Mullan,
M. H. Edwards, and E. E. Galyov.
1996.
SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry.
Mol. Microbiol.
22:327-338[Medline].
|
Infection and Immunity, November 1998, p. 5501-5507, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vidal, J. E., Navarro-Garcia, F.
(2006). Efficient Translocation of EspC into Epithelial Cells Depends on Enteropathogenic Escherichia coli and Host Cell Contact. Infect. Immun.
74: 2293-2303
[Abstract]
[Full Text]
-
Sharma, R., Tesfay, S., Tomson, F. L., Kanteti, R. P., Viswanathan, V. K., Hecht, G.
(2006). Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol.
290: G685-G694
[Abstract]
[Full Text]
-
Luo, W., Donnenberg, M. S.
(2006). Analysis of the Function of Enteropathogenic Escherichia coli EspB by Random Mutagenesis. Infect. Immun.
74: 810-820
[Abstract]
[Full Text]
-
Naylor, S. W., Roe, A. J., Nart, P., Spears, K., Smith, David. G. E., Low, J. C., Gally, D. L.
(2005). Escherichia coli O157 : H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires the LEE4 operon. Microbiology
151: 2773-2781
[Abstract]
[Full Text]
-
Garmendia, J., Frankel, G., Crepin, V. F.
(2005). Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation. Infect. Immun.
73: 2573-2585
[Full Text]
-
Shaw, R. K, Cleary, J., Murphy, M. S., Frankel, G., Knutton, S.
(2005). Interaction of Enteropathogenic Escherichia coli with Human Intestinal Mucosa: Role of Effector Proteins in Brush Border Remodeling and Formation of Attaching and Effacing Lesions. Infect. Immun.
73: 1243-1251
[Abstract]
[Full Text]
-
Li, M., Rosenshine, I., Tung, S. L., Wang, X. H., Friedberg, D., Hew, C. L., Leung, K. Y.
(2004). Comparative Proteomic Analysis of Extracellular Proteins of Enterohemorrhagic and Enteropathogenic Escherichia coli Strains and Their ihf and ler Mutants. Appl. Environ. Microbiol.
70: 5274-5282
[Abstract]
[Full Text]
-
Knappstein, S., Ide, T., Schmidt, M. A., Heusipp, G.
(2004). {alpha}1-Antitrypsin Binds to and Interferes with Functionality of EspB from Atypical and Typical Enteropathogenic Escherichia coli Strains. Infect. Immun.
72: 4344-4350
[Abstract]
[Full Text]
-
Navarro-Garcia, F., Canizalez-Roman, A., Sui, B. Q., Nataro, J. P., Azamar, Y.
(2004). The Serine Protease Motif of EspC from Enteropathogenic Escherichia coli Produces Epithelial Damage by a Mechanism Different from That of Pet Toxin from Enteroaggregative E. coli. Infect. Immun.
72: 3609-3621
[Abstract]
[Full Text]
-
Schmidt, H., Hensel, M.
(2004). Pathogenicity Islands in Bacterial Pathogenesis. Clin. Microbiol. Rev.
17: 14-56
[Abstract]
[Full Text]
-
Roe, A. J., Yull, H., Naylor, S. W., Woodward, M. J., Smith, D. G. E., Gally, D. L.
(2003). Heterogeneous Surface Expression of EspA Translocon Filaments by Escherichia coli O157:H7 Is Controlled at the Posttranscriptional Level. Infect. Immun.
71: 5900-5909
[Abstract]
[Full Text]
-
Batisson, I., Guimond, M.-P., Girard, F., An, H., Zhu, C., Oswald, E., Fairbrother, J. M., Jacques, M., Harel, J.
(2003). Characterization of the Novel Factor Paa Involved in the Early Steps of the Adhesion Mechanism of Attaching and Effacing Escherichia coli. Infect. Immun.
71: 4516-4525
[Abstract]
[Full Text]
-
Gauthier, A., Puente, J. L., Finlay, B. B.
(2003). Secretin of the Enteropathogenic Escherichia coli Type III Secretion System Requires Components of the Type III Apparatus for Assembly and Localization. Infect. Immun.
71: 3310-3319
[Abstract]
[Full Text]
-
Hauf, N., Chakraborty, T.
(2003). Suppression of NF-{kappa}B Activation and Proinflammatory Cytokine Expression by Shiga Toxin-Producing Escherichia coli. J. Immunol.
170: 2074-2082
[Abstract]
[Full Text]
-
Kenny, B.
(2002). Enteropathogenic Escherichia coli (EPEC) - a crafty subversive little bug. Microbiology
148: 1967-1978
[Full Text]
-
Tatsuno, I., Horie, M., Abe, H., Miki, T., Makino, K., Shinagawa, H., Taguchi, H., Kamiya, S., Hayashi, T., Sasakawa, C.
(2001). toxB Gene on pO157 of Enterohemorrhagic Escherichiacoli O157:H7 Is Required for Full Epithelial Cell Adherence Phenotype. Infect. Immun.
69: 6660-6669
[Abstract]
[Full Text]
-
Paton, A. W., Srimanote, P., Woodrow, M. C., Paton, J. C.
(2001). Characterization of Saa, a Novel Autoagglutinating Adhesin Produced by Locus of Enterocyte Effacement-Negative Shiga-Toxigenic Escherichia coli Strains That Are Virulent for Humans. Infect. Immun.
69: 6999-7009
[Abstract]
[Full Text]
-
Sandner, L., Eguiarte, L. E., Navarro, A., Cravioto, A., Souza, V.
(2001). The elements of the locus of enterocyte effacement in human and wild mammal isolates of Escherichia coli: evolution by assemblage or disruption?. Microbiology
147: 3149-3158
[Abstract]
[Full Text]
-
Suzuki, T., Sasakawa, C.
(2001). Molecular Basis of the Intracellular Spreading of Shigella. Infect. Immun.
69: 5959-5966
[Full Text]
-
Elliott, S. J., Krejany, E. O., Mellies, J. L., Robins-Browne, R. M., Sasakawa, C., Kaper, J. B.
(2001). EspG, a Novel Type III System-Secreted Protein from Enteropathogenic Escherichia coli with Similarities to VirA of Shigella flexneri. Infect. Immun.
69: 4027-4033
[Abstract]
[Full Text]
-
Goosney, D. L., DeVinney, R., Finlay, B. B.
(2001). Recruitment of Cytoskeletal and Signaling Proteins to Enteropathogenic and Enterohemorrhagic Escherichia coli Pedestals. Infect. Immun.
69: 3315-3322
[Abstract]
[Full Text]
-
Klein, J. R., Jones, B. D.
(2001). Salmonella Pathogenicity Island 2-Encoded Proteins SseC and SseD Are Essential for Virulence and Are Substrates of the Type III Secretion System. Infect. Immun.
69: 737-743
[Abstract]
[Full Text]
-
Mellies, J. L., Navarro-Garcia, F., Okeke, I., Frederickson, J., Nataro, J. P., Kaper, J. B.
(2001). espC Pathogenicity Island of Enteropathogenic Escherichia coli Encodes an Enterotoxin. Infect. Immun.
69: 315-324
[Abstract]
[Full Text]
-
Devinney, R., Nisan, I., Ruschkowski, S., Rosenshine, I., Finlay, B. B.
(2001). Tir Tyrosine Phosphorylation and Pedestal Formation Are Delayed in Enteropathogenic Escherichia coli sepZ::TnphoA Mutant 30-5-1(3). Infect. Immun.
69: 559-563
[Abstract]
[Full Text]
-
Ogierman, M. A., Paton, A. W., Paton, J. C.
(2000). Up-Regulation of Both Intimin and eae-Independent Adherence of Shiga Toxigenic Escherichia coli O157 by ler and Phenotypic Impact of a Naturally Occurring ler Mutation. Infect. Immun.
68: 5344-5353
[Abstract]
[Full Text]
-
Gauthier, A., de Grado, M., Finlay, B. B.
(2000). Mechanical Fractionation Reveals Structural Requirements for Enteropathogenic Escherichia coli Tir Insertion into Host Membranes. Infect. Immun.
68: 4344-4348
[Abstract]
[Full Text]
-
Tacket, C. O., Sztein, M. B., Losonsky, G., Abe, A., Finlay, B. B., McNamara, B. P., Fantry, G. T., James, S. P., Nataro, J. P., Levine, M. M., Donnenberg, M. S.
(2000). Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infect. Immun.
68: 3689-3695
[Abstract]
[Full Text]
-
Newman, J. V., Zabel, B. A., Jha, S. S., Schauer, D. B.
(1999). Citrobacter rodentium espB Is Necessary for Signal Transduction and for Infection of Laboratory Mice. Infect. Immun.
67: 6019-6025
[Abstract]
[Full Text]
-
Warawa, J., Finlay, B. B., Kenny, B.
(1999). Type III Secretion-Dependent Hemolytic Activity of Enteropathogenic Escherichia coli. Infect. Immun.
67: 5538-5540
[Abstract]
[Full Text]
-
Taylor, K. A., Luther, P. W., Donnenberg, M. S.
(1999). Expression of the EspB Protein of Enteropathogenic Escherichia coli within HeLa Cells Affects Stress Fibers and Cellular Morphology. Infect. Immun.
67: 120-125
[Abstract]
[Full Text]